Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 40
Filter
1.
Int J Obes (Lond) ; 38(11): 1416-22, 2014 Nov.
Article in English | MEDLINE | ID: mdl-24522245

ABSTRACT

BACKGROUND: Ethnic disparities in metabolic disease risk may be the result of differences in circulating adipokines and inflammatory markers related to ethnic variations in obesity and body fat distribution. SUBJECTS/METHODS: In a cross-sectional design, we compared serum levels of leptin, adiponectin, C-reactive protein (CRP), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) in control subjects (321 men and 930 women) from two nested case-control studies conducted within the Multiethnic Cohort Study consisting of whites, Japanese Americans (JA), Latinos, African Americans (AA) and Native Hawaiians (NH). General linear models were applied to evaluate ethnic differences in log-transformed serum biomarker levels before and after adjusting for body mass index (BMI) at cohort entry. RESULTS: In comparison to whites, significant ethnic differences were observed for all biomarkers except TNF-α. JA men and women had significantly lower leptin and CRP levels than whites, and JA women also had lower adiponectin levels. Leptin was significantly higher in AA women (P < 0.01), adiponectin was significantly lower in AA men and women (P = 0.02 and P < 0.001), and CRP and IL-6 were significantly higher in AA men and women. Lower adiponectin (P < 0.0001) and CRP (P = 0.03) levels were the only biomarkers in NH women that differed from whites; no statistically significant differences were seen for NH men and for Latino men and women. When adjusted for BMI at cohort entry, the differences between the lowest and the highest values across ethnic groups decreased for all biomarkers except adiponectin in men indicating that ethnic differences were partially due to weight status. CONCLUSIONS: These findings demonstrate the ethnic variations in circulating adipokine and CRP levels before and after adjustment for BMI. Given the limitation of BMI as a general measure of obesity, further investigation with visceral and subcutaneous adiposity measures are warranted to elucidate ethnicity-related differences in adiposity in relation to disparities in obesity-related disease risk.


Subject(s)
Adipokines/blood , C-Reactive Protein/metabolism , Obesity/blood , Racial Groups/statistics & numerical data , Black or African American/statistics & numerical data , Aged , Asian/statistics & numerical data , Biomarkers/blood , Body Fat Distribution , Body Mass Index , Case-Control Studies , Cohort Studies , Cross-Sectional Studies , Female , Follow-Up Studies , Hawaii/ethnology , Health Status Disparities , Hispanic or Latino/statistics & numerical data , Humans , Interleukin-6/blood , Leptin/blood , Male , Native Hawaiian or Other Pacific Islander/statistics & numerical data , Obesity/epidemiology , Obesity/ethnology , Tumor Necrosis Factor-alpha/blood , United States/epidemiology , White People/statistics & numerical data
2.
Eur J Clin Nutr ; 64(6): 652-4, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20216557

ABSTRACT

Although some evidence suggests a protective role of vitamin D against breast cancer, epidemiological findings are inconsistent. The current study investigated the relation of serum 25-hydroxyvitamin D (25(OH)D) levels with mammographic density. Baseline serum samples from 182 premenopausal women including 67 Caucasians and 74 Asians from a nutritional trial were analyzed for 25(OH)D. Mammographic density was assessed using a computer-assisted method. Serum 25(OH)D was not associated with mammographic density after adjustment for confounders (body mass index (BMI), age at mammogram, Asian ethnicity, age at first birth, parity and age at menarche). 25(OH)D levels were significantly lower in Asians than in Caucasians, but no significant ethnic differences in mammographic density were observed after adjusting for BMI. Although the current results indicate that serum 25(OH)D levels were not associated with mammographic density among premenopausal women, a possible protective effect of vitamin D against breast cancer may be mediated through other pathways.


Subject(s)
Breast Neoplasms/prevention & control , Breast/anatomy & histology , Mammography , Vitamin D/analogs & derivatives , Adult , Asian People , Body Mass Index , Breast Neoplasms/blood , Female , Humans , Image Processing, Computer-Assisted , Middle Aged , Premenopause , Vitamin D/blood , White People
3.
Nutr Cancer ; 39(1): 66-71, 2001.
Article in English | MEDLINE | ID: mdl-11588904

ABSTRACT

The tocopherols, the major vitamers of vitamin E, are believed to play a role in the prevention of human aging-related diseases such as cancer and heart disease, yet little is known concerning determinants of their plasma concentrations. Evidence from animal studies suggests that the dietary source of gamma-tocopherol can significantly affect plasma levels of this tocopherol as well as its functional vitamin E activity. To determine whether plasma levels of tocopherols in humans are similarly altered, a study was undertaken in which subjects (n = 9) were fed muffins containing equivalent amounts of gamma-tocopherol from sesame seeds, walnuts, or soy oil. We observed that consumption of as little as 5 mg of gamma-tocopherol per day over a three-day period from sesame seeds, but not from walnuts or soy oil, significantly elevated serum gamma-tocopherol levels (19.1% increase, p = 0.03) and depressed plasma beta-tocopherol (34% decrease, p = 0.01). No significant changes in baseline or postintervention plasma levels of cholesterol, triglycerides, or carotenoids were seen for any of the intervention groups. All subjects consuming sesame seed-containing muffins had detectable levels of the sesame lignan sesamolin in their plasma. Consumption of moderate amounts of sesame seeds appears to significantly increase plasma gamma-tocopherol and alter plasma tocopherol ratios in humans and is consistent with the effects of dietary sesame seeds observed in rats leading to elevated plasma gamma-tocopherol and enhanced vitamin E bioactivity.


Subject(s)
Antioxidants/administration & dosage , Sesame Oil/pharmacology , Tocopherols/blood , gamma-Tocopherol/administration & dosage , Adult , Aging/metabolism , Antioxidants/analysis , Bread , Chromatography, High Pressure Liquid , Dioxoles , Female , Food Analysis , Humans , Lignans , Male , Middle Aged , Nuts/chemistry , Seeds/chemistry , Soybean Oil/chemistry
4.
Free Radic Biol Med ; 31(4): 460-8, 2001 Aug 15.
Article in English | MEDLINE | ID: mdl-11498279

ABSTRACT

Autoantibodies against oxidized DNA bases are found in vivo and have been used as an indicator of oxidative damage, yet little is known concerning their individual variation and relation to serum micronutrients. Human plasma anti-5-hydroxymethyl-2'-deoxyuridine (HMdU) autoantibody (aAb) levels were repeatedly determined in 41 women and 11 men, and found to have small within-individual variation over time, but large between-individual differences. A positive association in both women (r = .5762, p = .0001) and men (r = .415, p = .2) between plasma total tocopherols and antibody levels was observed. Autoantibody levels were lower in postmenopausal women (8.37 +/- 1.61 vs. 17.18 +/- 2.85 in premenopausal women, p < .01), independently of plasma tocopherol. However, aAb titers in postmenopausal women were still significantly associated with plasma tocopherol levels and adjustment for menopausal status in women yielded a highly significant correlation between HMdU aAb levels and total tocopherol (r = .7342, p = .0001). Plasma malondialdehyde equivalents (MDA), a measure of lipid peroxidation, were also higher in individuals with either high plasma alpha-tocopherol or high beta+gamma-tocopherol levels. The positive association of tocopherols with markers of oxidative damage may reflect a response to the generation of endogenous oxidants associated with enhanced immune function. The decrease in aAb level in postmenopausal women may similarly reflect decreased immune function associated with decreased estrogen levels.


Subject(s)
Antineoplastic Agents/immunology , Autoantibodies/blood , Thymidine/analogs & derivatives , Thymidine/immunology , Tocopherols/blood , Adult , DNA/metabolism , Enzyme-Linked Immunosorbent Assay , Female , Free Radicals , Humans , Lipid Peroxidation , Male , Malondialdehyde/blood , Micronutrients/blood , Middle Aged , Neoplasms/prevention & control
5.
Carcinogenesis ; 21(11): 1989-95, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11062159

ABSTRACT

Nitric oxide synthase inhibitors block the neoplastic transformation of C3H 10T1/2 cells in vitro. Evidence presented herein suggests that they mediate their effects early in the carcinogenic process as brief treatment with the NOS inhibitor aminoguanidine (AG) during log phase cell growth (initiation phase) is sufficient to block foci formation. In contrast, treatment initiated after formation of a confluent monolayer was associated with diminished protection, while treatment commencing late in the promotional phase had no protective effect and appeared to enhance the number and stage of foci observed. These findings suggest that while AG treatment can inhibit transformation during the early promotional phase, it most effectively inhibits transformation during the initiation phase. In general AG enhanced growth of both normal and tumor cells, suggesting that effects on growth were unrelated to its anti-transformation properties, however, these effects could be related to the effect on tumor cell stage noted above. Although induction of inducible nitric oxide synthase (iNOS) by treatment with LI during the last 2 weeks of the assay was associated with enhanced transformation, the efficacy of AG in protecting against transformation was not clearly associated with substantial reductions in NO synthesis. The data suggest that AG inhibits transformation early in the transformation process independently of iNOS inhibition and that AG may have deleterious effects late in the process, possibly through stimulation of tumor cell growth.


Subject(s)
Cell Transformation, Neoplastic/metabolism , Fibroblasts/pathology , Nitric Oxide/physiology , Amines/metabolism , Animals , Cell Division/drug effects , Cell Transformation, Neoplastic/drug effects , Cell Transformation, Neoplastic/pathology , Cells, Cultured , Dose-Response Relationship, Drug , Embryo, Mammalian , Enzyme Inhibitors/pharmacology , Fibroblasts/drug effects , Fibroblasts/metabolism , Guanidines/pharmacology , Interferon-gamma/toxicity , Lipopolysaccharides/toxicity , Mice , Mice, Inbred C3H , Mutagens/toxicity , Neoplasms, Experimental/pathology , Nitric Oxide/toxicity , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide Synthase/biosynthesis , Nitric Oxide Synthase Type II , Nitrosation/drug effects
6.
Biochem Biophys Res Commun ; 277(2): 334-40, 2000 Oct 22.
Article in English | MEDLINE | ID: mdl-11032727

ABSTRACT

Preceding the onset of type 1 diabetes mellitus, pancreatic islets are infiltrated by macrophages secreting interleukin-1beta (IL-1beta) which induces beta-cell apoptosis and exerts inhibitory actions on islet beta-cell insulin secretion. IL-1beta seems to act chiefly through induction of nitric oxide (NO) synthesis. Hence, IL-1beta and NO have been implicated as key effector molecules in type 1 diabetes mellitus. In this paper, the influence of endogenously produced and exogenously delivered NO on the regulation of cell proliferation, cell viability and discrete parts of the stimulus-secretion coupling in insulin-secreting RINm5F cells was investigated. Because vitamin E may delay diabetes onset in animal models, we also investigated whether tocopherols may protect beta-cells from the suppressive actions of IL-1 and NO in vitro. To this end, the impact of NO on insulin secretory responses to activation of phospholipase C (by carbamylcholine), protein kinase C (by phorbol ester), adenylyl cyclase (by forskolin), and Ca(2+) influx through voltage-activated Ca(2+) channels (by K(+)-induced depolarization) was monitored in culture after treatment with IL-1beta or by co-incubation with the NO donor spermine-NONOate. It was found that cell proliferation, viability, insulin production and the stimulation of insulin release evoked by carbamylcholine and phorbol ester were impeded by IL-1beta or spermine-NONOate, whereas the hormone output by the other secretagogues was not altered by NO. Pretreatment with gamma-tocopherol (but not alpha-tocopherol) afforded a partial protection against the inhibitory effects of NO, whereas specifically inhibiting inducible NO synthase with N-nitro-L-arginine completely reversed the IL-1beta effects. In contrast, inhibiting guanylyl cyclase with ODQ (1H-[1,2, 4]oxadiazolo[4,3-alpha]-quinoxaline-1-one) or blocking low voltage-activated Ca(2+) channels with NiCl(2) failed to influence the actions of NO. In conclusion, our data show that NO inhibits growth and insulin secretion in RINm5F cells, and that gamma-tocopherol may partially prevent this. The results suggest that phospholipase C or protein kinase C may be targeted by NO. In contrast, cGMP or low voltage-activated Ca(2+) channels appear not to mediate the toxicity of NO in these cells. These adverse effects of NO on the beta-cell, and the protection by gamma-tocopherol, may be of importance for the development of the impaired insulin secretion characterizing type 1 diabetes mellitus, and offer possibilities for intervention in this process.


Subject(s)
Insulin/metabolism , Nitric Oxide/pharmacology , Vitamin E/metabolism , Vitamin E/physiology , Adenylyl Cyclases/metabolism , Animals , Calcium/metabolism , Calcium Channels/metabolism , Carbachol/pharmacology , Cell Division/drug effects , Cell Line , Cell Survival/drug effects , Cholinergic Agonists/pharmacology , Colforsin/pharmacology , Cyclic GMP/metabolism , Enzyme Inhibitors/pharmacology , Insulin Secretion , Insulinoma/metabolism , Interleukin-1/pharmacology , Islets of Langerhans/drug effects , Islets of Langerhans/metabolism , Models, Chemical , Nitric Oxide/metabolism , Nitrogen Oxides , Oxadiazoles/pharmacology , Phorbol Esters/pharmacology , Protein Kinase C/metabolism , Quinoxalines/pharmacology , Rats , Spermine/analogs & derivatives , Spermine/pharmacology , Type C Phospholipases/metabolism , Vitamin E/chemistry
7.
Nutr Cancer ; 34(2): 147-52, 1999.
Article in English | MEDLINE | ID: mdl-10578481

ABSTRACT

Heterocyclic aromatic amines (HAAs), a group of chemicals formed during high-temperature cooking of meat and fish, are potent mutagens and are suspected to play a role in colorectal cancer. A recent study suggested that marinating meat may offer a way to reduce HAA formation. Hawaii's diverse ethnic populations, which are at various risks of colorectal cancer, often use traditional marinades when cooking meat. We compared the HAA content of beef steaks marinated overnight with teriyaki sauce, turmeric-garlic sauce, or commercial honey barbecue sauce with that of unmarinated steaks. The levels of 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) were determined by liquid-liquid extraction and gas chromatography-mass spectrometry. Beef steaks marinated with teriyaki sauce had 45% and 67% lower PhIP level at 10 minutes (p = 0.002) and 15 minutes (p = 0.001) of cooking time as well as 44% and 60% lower MeIQx levels at 10 minutes (p = 0.008) and 15 minutes (p = 0.001), respectively, than unmarinated meat. Lower levels of PhIP and MeIQx were also observed in meat marinated with turmeric-garlic sauce. In contrast, marinating with barbecue sauce caused a 2.9- and 1.9-fold increase in PhIP (p < or = 0.005) and a 4- and 2.9-fold increase in MeIQx (p < or = 0.001) at 10 and 15 minutes, respectively. Differences in the mutagenic activities of marinated and unmarinated steaks, as measured by the Ames assay, paralleled the differences in PhIP and MeIQx levels. Future studies should test the effects of specific ingredients, including the water content of marinades, and the effect of reapplying barbecue sauce during cooking (to reduce charring) on HAA formation.


Subject(s)
Colorectal Neoplasms/chemically induced , Flavoring Agents , Meat , Asia , Cooking , Humans , Mutagenicity Tests , Risk Factors , Salmonella typhimurium/genetics , Western World
8.
Cancer Epidemiol Biomarkers Prev ; 8(10): 919-24, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10548322

ABSTRACT

Based on reports that fruits and vegetables may protect against breast cancer, this randomized intervention study tested the feasibility of increasing fruit and vegetable intake among healthy women to 9 daily servings through individual dietary counseling and group activities. Adherence to the dietary recommendations was monitored by 24-h food recalls, log sheets, and plasma carotenoid assessments. To explore possible cancer protective mechanisms of fruits and vegetables, we investigated the treatment effect on plasma phenol levels and on thiobarbituric acid-reactive substances measured as malondialdehyde equivalents, a possible marker of oxidative damage. At baseline, women in the intervention (n = 13) and control (n = 16) group reported an average daily consumption of 3.3 and 3.2 fruit and vegetable servings, respectively. After 3 and 6 months of intervention, intake in the intervention group had increased to 8.3 and 7.4 servings, whereas the control group reported an average of 4.2 and 4.1 daily servings. An increase of plasma carotenoid levels from 1249 microg/liter at baseline to 1854 and 1827 microg/liter after 3 and 6 months confirmed compliance with the dietary recommendations in the intervention group. Plasma carotenoid levels among controls changed slightly from 1165 to 1231 and 1291 microg/liter Whereas total phenol levels did not respond according to our hypothesis, malondialdehyde levels decreased slightly in the intervention group. These results suggest that motivated women can substantially increase their fruit and vegetable intake, which leads to a notable increase in plasma carotenoid levels.


Subject(s)
Breast Neoplasms/prevention & control , Feeding Behavior , Fruit , Vegetables , Adult , Breast Neoplasms/etiology , Carotenoids/blood , Female , Hawaii , Humans , Malondialdehyde/blood , Middle Aged
9.
J Natl Cancer Inst ; 91(5): 414-28, 1999 Mar 03.
Article in English | MEDLINE | ID: mdl-10070940

ABSTRACT

Efforts to elucidate the causes of prostate cancer have met with little success to date. All that is known with certainty is that the incidence increases exponentially with age, varies by geography and by race or ethnicity, and is higher among men whose father or brother had the disease. Because the incidence changes in migrants and their offspring, exogenous factors certainly contribute to the risk of prostate cancer. Early epidemiologic studies implicated dietary fat as a likely causal factor for this cancer. However, scientific support for such an association has diminished in recent years as more epidemiologic evidence has accrued. Accordingly, we reviewed the relevant English language literature on this topic, including epidemiologic and animal studies, as well as current concepts regarding the involvement of fat in carcinogenesis to re-examine the fat-prostate cancer hypothesis. We conclude that dietary fat may indeed be related to prostate cancer risk, although the specific fat components that are responsible are not yet clear. Given the diverse effects of fatty acids on cellular biology and chemistry, it seems likely that the relationship is complex, involving the interplay of fat with other dietary factors, such as antioxidant vitamins and minerals, or with genetic factors that influence susceptibility. Some suggestions for further research are offered.


Subject(s)
Dietary Fats/adverse effects , Dietary Fats/metabolism , Prostatic Neoplasms/etiology , Prostatic Neoplasms/metabolism , Humans , Male , Prostatic Neoplasms/epidemiology
10.
Cancer Lett ; 147(1-2): 163-73, 1999 Dec 01.
Article in English | MEDLINE | ID: mdl-10660102

ABSTRACT

Antisense phosphorothioate oligodeoxynucleotides (ODNs) are increasingly used to target specific proteins for inhibition. Previous reports of antisense inhibition of the inducible nitric oxide synthase (iNOS) gene suggested its utility in defining the role of nitric oxide (NO) in carcinogenesis, as NO is mutagenic and chemical inhibitors of iNOS block neoplastic transformation in C3H 10T1/2 fibroblasts. Treatment with ODNs (0.025-25 microM) directed against 15mer sequences in the iNOS coding region decreased NO production consistent with a reduction of iNOS protein and iNOS mRNA, however, control ODNs (2.5 microM) also showed considerable nonspecific inhibition of NO synthesis. Treatment with both iNOS antisense and missense ODNs during the promotional phase of the C3H10T1/2 transformation assay significantly increased the number of neoplastic foci in 3-methylcholanthrene (MCA) treated cells which corresponded with the ability of the ODN to inhibit NO production. Enhanced neoplastic transformation and non-specific inhibition of NO synthesis resulting from exposure to antisense ODNs suggest limitations to their long-term use in humans at higher doses.


Subject(s)
Aryl Hydrocarbon Hydroxylases , Cell Transformation, Neoplastic/drug effects , Fibroblasts/drug effects , Oligonucleotides, Antisense/pharmacology , Thionucleotides/pharmacology , Animals , Base Sequence , Blotting, Western , Carcinogens , Cell Line , Cell Transformation, Neoplastic/chemically induced , Cytochrome P-450 CYP1B1 , Cytochrome P-450 Enzyme System/genetics , Dose-Response Relationship, Drug , Enzyme Induction/drug effects , Fibroblasts/cytology , Fibroblasts/enzymology , Interferons/pharmacology , Lipopolysaccharides/pharmacology , Methylcholanthrene , Mice , Mice, Inbred C3H , Nitric Oxide/metabolism , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide Synthase/genetics , Nitric Oxide Synthase/metabolism , Nitric Oxide Synthase Type II , Oligonucleotides, Antisense/genetics , RNA, Messenger/metabolism , Thionucleotides/genetics , Transfection , Tumor Stem Cell Assay
11.
Adv Exp Med Biol ; 439: 237-48, 1998.
Article in English | MEDLINE | ID: mdl-9781307

ABSTRACT

Evaluation of unknown biological effects of chemicals including food plant products requires the assessment of bioactivity and bioavailability. Epidemiologic studies show consistently a cancer protective effect of fruit and vegetable consumption, but there is little understanding of which phytochemicals account for this observation. Commonly studied antioxidant micronutrients are less consistently correlated with cancer protection relative to the food groups themselves, suggesting that other phytochemicals or a combination of food products play key roles in preventing cancer. We investigated the effects of the predominant dietary flavonoids and isoflavonoids at inhibiting neoplastic transformation induced by 3-methylcholanthrene in C3H 10T1/2 murine fibroblasts. We found that most phenolic agents tested were equal to or superior to known chemopreventive agents such as carotenoids or vitamins in effectiveness. Hesperetin, hesperidin and catechin were the most potent agents among the flavonoids tested, inhibiting transformation completely when applied at 1.0 microM after exposure to the carcinogen. Structure-activity comparison revealed that among the compounds tested, flavonoids with a vicinal diphenol structure in ring 'B' and a saturated 'C' ring exhibited the strongest effects. Most agents tested showed dose-dependent patterns. Interestingly, the soy isoflavonoids were weakly active except when applied in combination, suggesting a synergistic effect. In addition, HPLC techniques were developed for determining the bioavailability of isoflavonoids in human biological fluids including urine, plasma and breast milk. We observed a relatively fast absorption, distribution and elimination of isoflavonoids including a biphasic pattern probably due to enterohepatic circulation. Total peak isoflavone levels in urine, plasma and in breast milk were found to be 60 microM, 2 microM and 0.2 microM, respectively and were reached 8-12 hours after consumption of soy foods. Levels detected in human body fluids were found to be highly active at inhibiting neoplastic transformation, especially considering synergistic effects observed for combinations of daidzein and genistein, the predominant isoflavonoids occurring in soy foods.


Subject(s)
Cell Transformation, Neoplastic/drug effects , Diet , Flavonoids/administration & dosage , Animals , Antineoplastic Agents/administration & dosage , Fibroblasts/pathology , Humans , Mice , Neoplasms/prevention & control
12.
Cancer Lett ; 122(1-2): 67-75, 1998 Jan 09.
Article in English | MEDLINE | ID: mdl-9464493

ABSTRACT

Tamoxifen (TAM) is used in the prevention and treatment of breast cancer, however, its mechanisms of therapeutic action as well as its pathologic effects are not fully understood. We report that TAM (10(-7)-10(-5) M) inhibits 3-methylcholanthrene-induced transformation of C3H 10T1/2 murine fibroblasts in a dose-responsive manner. Over this concentration range, TAM (>10(-6) M) potentiates inducible nitric oxide synthase (iNOS) activity in 10T1/2 cells. This increase in NO synthase activity was mediated through an increase in iNOS protein for cells stimulated with interferon-gamma (IFN-gamma) and bacterial lipopolysaccharide (LPS). Significant increases in NO formation were observed when TAM (10(-5)) was added prior to or simultaneously with IFN-gamma/LPS treatment, whereas the addition of TAM 48 h after IFN-gamma/LPS treatment had no effect on NO synthesis. The morphologic changes seen with cells treated with TAM are similar to those observed in cells treated with TGF-beta1. TGF-beta1 inhibited NO production at high doses and slightly enhanced NO formation at low doses in IFN-gamma/LPS-stimulated cells. The transformation inhibitory effects of TAM did not appear to be related to the effects on cellular proliferation of neoplastic cells as TAM did not inhibit the growth of neoplastic cells into foci in the presence of normal confluent C3H 10T1/2 fibroblasts.


Subject(s)
Cell Transformation, Neoplastic/drug effects , Estrogen Antagonists/pharmacology , Nitric Oxide/biosynthesis , Tamoxifen/pharmacology , Animals , Mice , Mice, Inbred C3H
13.
Pharmacogenetics ; 7(1): 11-9, 1997 Feb.
Article in English | MEDLINE | ID: mdl-9110357

ABSTRACT

Cytochrome CYP1A2, a liver enzyme responsible for the metabolic activation of a number of putative human carcinogens, exhibits wide inter-individual differences in activity. In order to characterize sources of variability in CYP1A2 activity, we phenotyped (with the caffeine test) 90 subjects of various ethnic backgrounds in Hawaii. Forty-three subjects were patients with in-situ colorectal cancer treated by polypectomy and 47 were healthy population controls. Subjects were also administered a detailed lifestyle questionnaire, including a quantitative food frequency questionnaire, and were assessed for plasma levels of carotenoids, tocopherols, retinol, ascorbic acid, cholesterol and triglycerides. In a stepwise multiple regression, 27% of the overall variation in CYP1A2 activity was explained by seven variables. Plasma lutein explained the largest portion of the variance (7%) and was negatively associated with CYP1A2 activity (p < 0.01), as were use of menopausal replacement estrogens (p = 0.04), plasma alpha-tocopherol (p = 0.05) and alcohol consumption (p = < 0.01). Acetaminophen use (p = 0.05), coffee consumption (p = 0.05) and plasma lycopene (p = 0.06) were positively associated with CYP1A2 activity. After adjustment for these variables, no association was found between CYP1A2 activity and sex, race, age, education, smoking, physical activity, weight, vitamin E supplements, the other plasma micronutrients measured, and dietary intakes of red meat, processed meat and cruciferous vegetables. Results were similar for colorectal cancer cases and controls. Almost two-thirds (73%) of the variability in CYP1A2 activity remained unexplained. This study confirms an enhancing effect of acetaminophen and coffee on CYP1A2 activity and suggests and inhibitory effect of estrogens, alcohol and food sources of lutein and alpha-tocopherol on this enzyme.


Subject(s)
Cytochrome P-450 CYP1A2/metabolism , Diet , Life Style , Lutein/blood , Vitamin E/blood , Adult , Age Factors , Aged , Aged, 80 and over , Caffeine , Case-Control Studies , Coffee , Colorectal Neoplasms/epidemiology , Education , Female , Humans , Male , Middle Aged , Phenotype , Regression Analysis , Sex Characteristics , Smoking
14.
Cancer Epidemiol Biomarkers Prev ; 5(6): 449-55, 1996 Jun.
Article in English | MEDLINE | ID: mdl-8781741

ABSTRACT

To determine whether NAT2 genotyping could be used interchangeably with caffeine phenotyping in assessing N-acetyltransferase activity in epidemiological studies, sources of interindividual variability in N-acetyltransferase activity were assessed among 90 subjects of various ethnic backgrounds in Hawaii. Forty-three subjects were patients with in situ colorectal cancer treated by polypectomy, and 47 were healthy population controls. Subjects were administered a lifestyle questionnaire and were evaluated for N-acetyltransferase activity by caffeine phenotyping. NAT2 genotype was also assessed by PCR amplification of peripheral leukocyte DNA for the M1, M2, and M3 variant alleles. Fifty-four % of the overall variation in acetylation activity was explained by the three genotype categories (homozygous variant, heterozygous, and homozygous wild-type). This proportion was reduced to 42% when genotype was modeled using only two categories ("slow" being homozygous variant; "rapid" being all others). Use of gout medications (probenecid or allopurinol), consumption of heavily browned fish, and P450IA2 activity (also measured by caffeine phenotyping), together explained another 11% of the variance. No association was found between acetylation activity and sex; race; age; education; smoking; physical activity; weight; consumption of coffee, alcohol, red meat, processed meat, and cruciferous vegetables; or use of menopausal estrogens, after taking genotype into account. Results were similar for colorectal cancer patients and controls. Considerable variation in acetylation activity was observed within the homozygous wild-type group. This study suggests that the use of genotyping, instead of phenotyping, to assess the association of acetylation with cancer risk is unlikely to introduce major misclassification or bias, especially when the three genotype categories are modeled and the sample size is large. However, when the rapid acetylation phenotype is the at-risk group (e.g., when studying colon career), phenotyping appears judicious given the variability in acetylation activity within this group.


Subject(s)
Adenomatous Polyposis Coli/genetics , Arylamine N-Acetyltransferase/genetics , Caffeine/pharmacokinetics , Genotype , Phenotype , Acetylation , Adult , Aged , Alleles , Female , Humans , Male , Middle Aged , Polymerase Chain Reaction , Risk Factors
15.
Free Radic Biol Med ; 19(3): 259-69, 1995 Sep.
Article in English | MEDLINE | ID: mdl-7557540

ABSTRACT

gamma-Tocopherol, commonly found in seed oils, is the major tocopherol in the U.S. diet, is superior to alpha-tocopherol in preventing neoplastic transformation, and demonstrates unique reactivity toward NO2. This article describes the products of reaction between gamma-tocopherol and low concentrations of gaseous nitrogen dioxide (NO2), as well as their endogenous formation in NO-producing RINm5F cells. gamma-Tocopherol in hexane reacts with NO2 to yield two products identified as 2,7,8-trimethyl-2(4,8,12-trimethyltridecyl)-5,6-chromaquinone++ +, "tocored," and 2,7,8 trimethyl-2(4,8,12-trimethyltridecyl) 5-nitro, 6-chromanol, "tocoyellow." Physical data for these two compounds and reaction characteristics are described. The formation of tocored is consistent with a proposed mechanism of gamma-tocopherol-mediated reduction of NO2 to NO involving initial reaction by NO2 at the C-5 position to form an intermediate nitrite ester tocopheryl radical, which then reacts internally to release NO and form 5,6 epoxy gamma-tocopherol. Tautomerization and further oxidation of the latter intermediate by NO2 yields tocored as the main product observed. The reaction of gamma-tocopherol with NO2 to form NO occurs independently of light, whereas alpha-tocopherol requires light to generate NO from NO2. gamma-Tocopherol and aminoguanidine, an NO synthase inhibitor, were superior to alpha-tocopherol in preventing RINm5F cell toxicity induced by Interleukin-1 beta (IL-1 beta). Both tocored and tocoyellow were observed to form in RINm5F cells loaded with gamma-tocopherol and producing NO constitutively, although a consistent increase in these products as a result of induced NO synthesis was not observed.


Subject(s)
Insulinoma/metabolism , Nitric Oxide/chemistry , Nitric Oxide/metabolism , Pancreatic Neoplasms/metabolism , Vitamin E/chemistry , Vitamin E/metabolism , Animals , Biotransformation , Cell Line , Chromatography, High Pressure Liquid , Kinetics , Magnetic Resonance Spectroscopy , Mass Spectrometry , Molecular Structure , Oxidation-Reduction , Rats , Time Factors , Tumor Cells, Cultured
16.
Article in English | MEDLINE | ID: mdl-7606195

ABSTRACT

Plasma samples were collected at monthly intervals for a period of 1 year from a group of healthy nonsmoking men and women (n = 21) living in Honolulu, HI. Analysis of plasma cholesterol and triglyceride levels showed marked seasonal variations, with higher mean levels in winter months and lower values in the summer. Cholesterol and triglycerides were highly and inversely correlated with plasma levels of the provitamin A carotenoids. Mean beta- and alpha-carotene levels were highest in late summer and fall. Plasma retinol levels were significantly lower in the summer and higher in the winter. Variations (either between individuals or seasonally) in plasma retinol were unrelated to plasma provitamin A carotenoid levels. Plasma levels of alpha-tocopherol, gamma-tocopherol, beta-cryptoxanthin, and lutein were also higher in the winter and lower in the summer. Significant seasonal correlations, both positive and negative, with environmental variables, such as temperature, solar UV radiation, and rainfall, are noted for many of these plasma micronutrients. The number of samples required to accurately characterize long-term plasma levels for an individual generally ranged from 1 to 4. However, plasma retinol levels exhibited the highest ratio of intra- to interindividual variability, suggesting the need for multiple sampling (> 8 samples) for this micronutrient. Some of this variability for retinol was associated with seasonal changes. Assessment by a diet history of food and supplement intake of micronutrients and phytochemicals for 1 year showed good agreement with 1-year mean plasma levels for most carotenoids, vitamin C, and alpha-tocopherol. Retinol, gamma-tocopherol, cholesterol, and triglyceride levels in plasma were unrelated to estimates of dietary intake.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Antioxidants/pharmacokinetics , Seasons , Trace Elements/blood , Adult , Ascorbic Acid/blood , Carotenoids/blood , Cholesterol/blood , Feeding Behavior , Female , Hawaii , Humans , Male , Middle Aged , Nutritional Requirements , Reference Values , Triglycerides/blood , Vitamin A/blood , Vitamin E/blood
17.
Article in English | MEDLINE | ID: mdl-7541679

ABSTRACT

Increased mutagen sensitivity and decreased intake of antioxidant-rich fruits and vegetables have been associated with an increased risk of upper aerodigestive tract cancers. The objective of this study was to investigate the intraindividual variation in mutagen sensitivity and its possible correlation with plasma nutrient levels in a group of 25 healthy individuals in Hawaii. Mutagen sensitivity, as assessed by bleomycin-induced chromosomal breaks in cultured peripheral blood lymphocytes and plasma nutrient levels were measured monthly for 11 months. The monthly numbers of chromosomal breaks/cell ranged from 0.04 to 0.80 and showed considerable intraindividual variation. Based on individual means, significant inverse correlations were found between mutagen sensitivity scores and the plasma levels of alpha-carotene (r = -0.64), total carotenoids (r = -0.41), and ascorbic acid (r = -0.40). There were also significant inverse associations between monthly mean plasma levels of alpha-carotene (r = -0.58), beta-carotene (r = -0.76) and total carotenoids (r = -0.72) and monthly mean chromosomal breaks. In contrast, there was a significant positive correlation between monthly mean plasma triglyceride level (r = 0.60) and monthly mean mutagen sensitivity. These results suggest that mutagen sensitivity as assessed by the bleomycin assay may be influenced by plasma levels of certain nutrients and could potentially be modified by dietary interventions or micronutrient supplementation.


Subject(s)
Antioxidants/pharmacology , Mutagenicity Tests , Trace Elements/blood , Adult , Aged , Ascorbic Acid/blood , Bleomycin , Carotenoids/blood , Cholesterol/blood , Chromosome Aberrations , Feeding Behavior , Female , Hawaii , Humans , Male , Middle Aged , Reference Values , Risk Factors , Seasons , Triglycerides/blood , Vitamin A/blood , Vitamin E/blood
18.
Environ Health Perspect ; 102(5): 460-2, 1994 May.
Article in English | MEDLINE | ID: mdl-8593849

ABSTRACT

Plants are more susceptible to the toxic effects of nitrogen dioxide when exposure takes place in the dark. Beta-carotene and other common carotenoids react with nitrogen dioxide in the dark to yield intermediate nitrosating agents consistent with the formation of nitrate esters. Simultaneous exposure of carotenoids to NO2 and light significantly reduced formation of nitrosating intermediates and resulted in the release of nitric oxide (NO) into the gas phase. Light-mediated reduction of NO2 to NO by carotenoids may be an important mechanism for preventing damage in plants exposed to NO2. The formation of nitrosating agents from the reaction of carotenoids with NO2 suggests that their ability to prevent nirosative damage associated with NO2 exposure in both plants and animals may be limited in the absence of light.


Subject(s)
Carotenoids/metabolism , Nitric Oxide/metabolism , Nitrogen Dioxide/metabolism , Animals , Antioxidants/metabolism , Darkness , Environmental Health , Humans , Light , Nitrogen Dioxide/toxicity , Plants/metabolism , Plants/radiation effects , beta Carotene
19.
Article in English | MEDLINE | ID: mdl-8019375

ABSTRACT

The authors examined the feasibility of using plasma carotenoids and ascorbic acid as markers of compliance for dietary intervention trials aimed at increasing the quantity and variety of the fruit and vegetable intake of free-living individuals. Nineteen former cancer patients who had been successfully treated for a stage I or II squamous cell carcinoma of the mouth, pharynx, larynx, or lung were recruited. Subjects served as their own controls. However, in order to detect any seasonal trends, 4 individuals among the 19 were randomized to a nonintervention group. Subjects in the intervention group were counseled by dietitians with the goal of increasing their intake of fruits and vegetables to eight servings/day (1 serving each of dark green vegetables, yellow-orange vegetables, tomato products, and other vegetables; 3 servings of vitamin C-rich fruits; and 1 serving of other fruits). Subjects in the nonintervention group were advised to follow their usual diet. Three-day measured food records kept at base line and after 3 months of intervention, as well as unannounced 24-h dietary recalls, documented an increase in mean fruit and vegetable intake from 4.2 to 9.5 servings daily in the intervention group. A concomitant increase of 29% was observed in total plasma carotenoids (P = 0.02), with increases of 25% for plasma lycopene (P = 0.06), 31% for plasma lutein (P = 0.002), 39% for plasma beta-carotene (P = 0.01), and 57% for plasma alpha-carotene (P = 0.01). Mean plasma levels of ascorbic acid increased by 27% (P < 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Ascorbic Acid/blood , Carcinoma, Squamous Cell/blood , Carcinoma, Squamous Cell/diet therapy , Carotenoids/blood , Fruit , Head and Neck Neoplasms/blood , Head and Neck Neoplasms/diet therapy , Lung Neoplasms/blood , Lung Neoplasms/diet therapy , Patient Compliance , Vegetables , Aged , Biomarkers/blood , Carcinoma, Squamous Cell/epidemiology , Diet Records , Female , Head and Neck Neoplasms/epidemiology , Humans , Lung Neoplasms/epidemiology , Lutein/blood , Lycopene , Male , Middle Aged , Nutritional Sciences/education , Pilot Projects , Seasons
20.
Cancer Lett ; 79(1): 17-26, 1994 Apr 29.
Article in English | MEDLINE | ID: mdl-7910514

ABSTRACT

Plasma levels of triglycerides, retinol, cholesterol, lipid-phase antioxidants (alpha-, gamma-tocopherols, beta-carotene, alpha-carotene, lycopene, beta-cryptoxanthin and lutein/zeaxanthin), and thiobarbituric acid-reactive substances (TBA-RS), as an indicator of lipid peroxidation, were repeatedly determined in nine individuals over a 3-month period. Levels of TBA-RS were positively correlated with plasma triglycerides and gamma-tocopherol, and negatively correlated with plasma carotenoids. These results were consistent with in vitro cell culture studies which showed increased TBA-RS for cells supplemented with linolenic acid and decreased levels when treated with beta-carotene. We conclude that TBA-RS measurements in plasma accurately reflect the level of peroxidizable substrate as modified by the presence of a variety of dietary antioxidants, particularly carotenoids. Although the inter- and intra-individual variabilities for TBA-RS are comparable with the micronutrients and antioxidants measured in this study, high interassay variability and the strong association with the more commonly measured plasma triglycerides suggest the TBA-RS assay to be of limited use in epidemiologic studies. However, this assay does appear to be useful in cell culture studies where experimental conditions can be better controlled. Low ratios of inter- to intra-individual variability in some of the plasma micronutrient and lipid-phase antioxidants measured suggest that multiple samples may be required to characterize individuals in studies evaluating the relation between these plasma constituents and disease incidence.


Subject(s)
Antioxidants/metabolism , Lipid Peroxidation/physiology , Animals , Carotenoids/analogs & derivatives , Carotenoids/blood , Carotenoids/pharmacology , Cells, Cultured , Cholesterol/blood , Cryptoxanthins , Fibroblasts/drug effects , Fibroblasts/metabolism , Humans , Lipid Peroxidation/drug effects , Lutein/blood , Lycopene , Mice , Mice, Inbred C3H , Thiobarbituric Acid Reactive Substances/analysis , Time Factors , Triglycerides/blood , Vitamin A/blood , Vitamin E/blood , Xanthophylls , Zeaxanthins , alpha-Linolenic Acid/pharmacology , beta Carotene
SELECTION OF CITATIONS
SEARCH DETAIL
...